01046nam2-22003251i-450-99000579433040332120080515120627.0000579433FED01000579433(Aleph)000579433FED0100057943319990604d1914----km-y0itay50------baitay-------001yyAgostino ed il Dogma in OccidenteAdolfo Harnack1. versione italiana sulla 4. ed. tedescaMendrisioSvizzeraCasa Editrice Cultura Moderna1914425 p.22 cmBiblioteca economica di scienze religiose11 ; 00120010005794232001Manuale di storia del dogmaAdolfo Harnack5DogmaStoria230.2Harnack,Adolf von<1851-1930>177526ITUNINARICAUNIMARCBK990005794330403321230.2 HAR 1 (5)BIBL. 4948FLFBCFLFBCAgostino ed il Dogma in Occidente569291UNINA04383oam 2201261zu 450 991069823550332120251017110057.0(CKB)3450000000002075(SSID)ssj0000622399(PQKBManifestationID)11383848(PQKBTitleCode)TC0000622399(PQKBWorkID)10642367(PQKB)22010915(WaSeSS)Ind00030679(OCoLC)77638732(DNLM)1304422(EXLCZ)99345000000000207520160829d2007 uy engur|||||||||||txtccrTesting for cytochrome P450 polymorphisms in adults with non-psychotic depression treated with selective serotonin reuptake inhibitors (SSRIs[Place of publication not identified]AHRQ20071 online resourceEvidence report/technology assessment Testing for cytochrome P450 polymorphisms in adults with non-psychotic depression treated with selective serotonin reuptake inhibitors (SSRIs)Bibliographic Level Mode of Issuance: MonographIncludes bibliographical references.Evidence report/technology assessment ;no. 146.AHRQ publication ;no. 07-E002.Serotonin uptake inhibitorsChemotherapyCytochrome P-450Depression, MentalPharmacogeneticsGenetic VariationDepressive DisorderSerotonin AgentsAge GroupsNeurotransmitter Uptake InhibitorsCytochromesMixed Function OxygenasesHemeproteinsGenetic PhenomenaMood DisordersPersonsNeurotransmitter AgentsOxygenasesEnzymes and CoenzymesProteinsMolecular Mechanisms of Pharmacological ActionPhysiological Effects of DrugsOxidoreductasesMental DisordersPharmacologic ActionsAmino Acids, Peptides, and ProteinsEnzymesChemical Actions and UsesPolymorphism, GeneticCytochrome P-450 Enzyme SystemAdultMajor Depressive DisorderSelective Serotonin Reuptake InhibitorsHealth & Biological SciencesHILCCPharmacy, Therapeutics, & PharmacologyHILCCSerotonin uptake inhibitorsChemotherapy.Cytochrome P-450.Depression, Mental.Pharmacogenetics.Genetic Variation.Depressive Disorder.Serotonin Agents.Age Groups.Neurotransmitter Uptake Inhibitors.Cytochromes.Mixed Function Oxygenases.Hemeproteins.Genetic Phenomena.Mood Disorders.Persons.Neurotransmitter Agents.Oxygenases.Enzymes and Coenzymes.Proteins.Molecular Mechanisms of Pharmacological Action.Physiological Effects of Drugs.Oxidoreductases.Mental Disorders.Pharmacologic Actions.Amino Acids, Peptides, and Proteins.Enzymes.Chemical Actions and Uses.Polymorphism, Genetic.Cytochrome P-450 Enzyme System.Adult.Major Depressive Disorder.Selective Serotonin Reuptake Inhibitors.Health & Biological SciencesPharmacy, Therapeutics, & Pharmacology615/.78Matchar David B.United States Agency for Healthcare Research and QualityDuke University Evidence-based Practice Center,PQKBBOOK9910698235503321Testing for cytochrome P450 polymorphisms in adults with non-psychotic depression treated with selective serotonin reuptake inhibitors (SSRIs3140792UNINA